Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR-Mutated Advanced NSCLC

Original Article

W. Fang, L. Wu, X. Meng, Y. Yao, W. Zuo, W. Yao, Y. Xie, Y. Zhang, J. Cui, Y. Zhang, X. Li, W. Zhuang, J. Fang, Q. Wang, W. Jiang, K. Li, Y. Bai, Y. Luo, F. Ma, Y. Yu, W. Zheng, Z. Liu, B. Yang, R. Ma, Y. Fang, R. Yang, L. Jiang, J. Hu, J. Yang, Y. Diao, X. Jin, J. Ge, Y. Yang, and L. Zhang

N Engl J Med 2026;394:13-26

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
12/31/2025
Course expires: 
01/01/2028

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Please sign in or create an account to take the course.